Cigna Group $CI Shares Sold by McAdam LLC

McAdam LLC lowered its holdings in Cigna Group (NYSE:CI) by 10.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,254 shares of the health services provider’s stock after selling 145 shares during the period. McAdam LLC’s holdings in Cigna Group were worth $415,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CI. Brighton Jones LLC grew its holdings in Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares in the last quarter. Ameriflex Group Inc. acquired a new stake in Cigna Group during the 4th quarter valued at $44,000. Park Square Financial Group LLC acquired a new stake in Cigna Group during the 4th quarter valued at $62,000. Wealth Enhancement Advisory Services LLC grew its holdings in Cigna Group by 92.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 102,647 shares of the health services provider’s stock valued at $28,345,000 after purchasing an additional 49,420 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in Cigna Group by 11.1% during the 4th quarter. Wellington Management Group LLP now owns 16,869 shares of the health services provider’s stock valued at $4,658,000 after purchasing an additional 1,689 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Down 2.5%

NYSE CI opened at $284.06 on Friday. The company’s fifty day moving average price is $292.89 and its two-hundred day moving average price is $310.72. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The company has a market capitalization of $75.83 billion, a price-to-earnings ratio of 15.51, a price-to-earnings-growth ratio of 0.85 and a beta of 0.48.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period last year, the firm posted $6.72 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CI. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Guggenheim reiterated a “buy” rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Wells Fargo & Company reduced their price objective on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the company a “buy” rating in a research note on Tuesday, August 5th. Finally, Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.